Abstract: Disclosed herein are methods of treating a disease in a subject which is the consequence of previous exposure of the subject to a virus, particularly SARS-CoV-2, the method comprising administration of an effective amount of one or more agents to the subject.

Abstract: The present invention is directed to the integration of various services under one platform and mimicking the role of a physician within a personal computing device such as a smartphone. The present invention may provide the User with a diagnosis of abnormalities through dialogue and provide prescriptions and treatment plans. The present invention may comprise an external communicator module for communicating with a plurality of external medical sources to compile the user's medical records into a single format. The present invention may further comprise a diagnosis module that uses the user's medical records and a database of all diseases and symptoms to automatically diagnose an ailment in a user and treatment options for said ailment. The present invention may further comprise a case monitoring module for tracking the recovery time of the user and adjusting the recovery time if a change in treatment is executed.

Abstract: Disclosed herein are methods of treating a disease in a subject which is the consequence of previous exposure of the subject to a virus, particularly SARS-CoV-2, the method comprising administration of an effective amount of one or more agents to the subject.

Abstract: Disclosed herein are methods of treating a disease in a subject which is the consequence of previous exposure of the subject to a virus, particularly SARS-CoV-2, the method comprising administration of an effective amount of one or more agents to the subject.

Abstract: The present invention is directed to the integration of various services under one platform and mimicking the role of a physician within a personal computing device such as a smart phone. The present invention may provide the User with diagnosis of abnormalities thorough dialogue and provide prescriptions and treatment plan. The present invention may comprise an external communicator module for communicating with a plurality of external medical sources to compile the user's medical records into a single format. The present invention may further comprise a diagnosis module that uses the user's medical records and a database of all diseases and symptoms to automatically diagnose an ailment in a user and treatment options for said ailment. The present invention may further comprise a case monitoring module for tracking a recovery time of the user and adjusting the recovery time if a change in treatment is executed.

Abstract: Provided herein is a method for treating cancer in a patient in need thereof, wherein said cancer has a tumor proportion score (TPS) for programmed death receptor-1 (PD-1) or programmed death-ligand-1 (PD-L1) of 50% or less and said patient is negative for lymphatic dysfunction, comprising administering a therapeutically effective amount of an antagonist for immune checkpoint inhibition.

Abstract: Provided herein is a method for treating cancer in a patient in need thereof, wherein said cancer has a tumor proportion score (TPS) for programmed death receptor-1 (PD-1) or programmed death-ligand-1 (PD-L1) of 50% or less and said patient is negative for lymphatic dysfunction, comprising administering a therapeutically effective amount of an antagonist for immune checkpoint inhibition.

Abstract: Provided herein is a method for determining cancer treatment using an immune-modulating therapy in a subject in need thereof. The method comprises assessing whether a lymphatic system in a subject is dysregulated. When the lymphatic system is dysregulated, a treatment for the lymphatic system is determined before a therapeutic amount of an immune-modulating therapy is administered to treat cancer in the subject. Alternatively, when the lymphatic system is dysregulated, an immune-modulating therapy is selected to treat cancer in the subject. The immune-modulating therapy is independent of immune-cell priming, antigen trafficking, antigen presentation, and any combination thereof. The subject may also be treated for cancer accordingly.

Abstract: Provided herein is a method for treating cancer in a patient in need thereof, wherein said cancer has a tumor proportion score (TPS) for programmed death receptor-1 (PD-11) or programmed death-ligand-1 (PD-L1) of 50% or less and said patient is negative for lymphatic dysfunction, comprising administering a therapeutically effective amount of an antagonist for immune checkpoint inhibition.

Abstract: Provided herein is a method for determining cancer treatment using an immune modulating therapy in a subject in need thereof. The method comprises assessing whether a lymphatic system in a subject is dysregulated. When the lymphatic system is dysregulated, a treatment for the lymphatic system is determined before a therapeutic amount of an immune modulating therapy is administered to treat cancer in the subject. Alternatively, when the lymphatic system is dysregulated, an immune modulating therapy is selected to treat cancer in the subject, which immune modulating therapy is independent of immune-cell priming, antigen trafficking, antigen presentation, and any combination thereof. The subject may also be treated for cancer accordingly.

Abstract: Provided herein is a method for determining cancer treatment using an immune modulating therapy in a subject in need thereof. The method comprises assessing whether a lymphatic system in a subject is dysregulated. When the lymphatic system is dysregulated, a treatment for the lymphatic system is determined before a therapeutic amount of an immune modulating therapy is administered to treat cancer in the subject. Alternatively, when the lymphatic system is dysregulated, an immune modulating therapy is selected to treat cancer in the subject, which immune modulating therapy is independent of immune-cell priming, antigen trafficking, antigen presentation, and any combination thereof. The subject may also be treated for cancer accordingly.

Abstract: An intelligent battery optimization management and equalization system that also monitors all cells within a battery, The system will ensure all cells are charged to maximum capacity, discharges the full capacity of each cell, perform equalization of charges between all the cells, manages and monitors each cell within a battery pack, The system further includes a multi-pulse rectifier transformer to efficiently and reliably convert high voltage AC input from power grids to DC voltage to effectively charge electric vehicles, industrial electrical vehicles, electric buses, portable battery packs, and/or battery-operated vehicles,

Abstract: An intelligent battery optimization management and equalization system that also monitors all cells within a battery. The system will ensure all cells are charged to maximum capacity, discharges the full capacity of each cell, perform equalization of charges between all the cells, manages and monitors each cell within a battery pack.

Abstract: Provided herein is a method, including forming a first template including a first pattern, wherein forming the first template includes self-assembly of diblock copolymers guided by an initial pattern; forming a second template including a second pattern, wherein the second pattern corresponds to a servo pattern; and forming a master template from the first template, wherein the master template includes one or more portions of the first pattern combined with the second pattern.

Abstract: Provided herein is a method, including a) transferring an initial pattern of an initial template to a substrate; b) performing block copolymer self-assembly over the substrate with a density multiplication factor k; c) creating a subsequent pattern in a subsequent template with the density multiplication factor k; and d) repeating steps a)-c) with the subsequent template as the initial template until a design specification for the subsequent pattern with respect to pattern density and pattern resolution is met.

Abstract: A method for constructing an association map between imaging features and biological data is described. The method comprises combining one or more image features relating to a clinical subject with biological data and using an algorithm to make predictions based on the features and data.

Abstract: Techniques and mechanisms for formatting digital audio-video (“AV”) information. In an embodiment, interface logic includes circuitry to receive digital AV information which, in one or more respects, is according to or otherwise compatible with a first interface specification. The interface logic changes a format of the digital AV information to allow for subsequent physical layer processing which is according to a second interface specification. In another embodiment, conversion logic receives analog signals according to the second interface specification and, based on such analog signals, performs digital information processing for subsequent generation of other analog signals to be transmitted according to the first interface specification.

Abstract: Provided herein is a method including conformally depositing a first layer over a patterned resist; depositing a second, thicker layer over the first layer; etching the second layer to expose the first layer; and patterning a magnetic layer by ion implantation in accordance with the patterned resist to form a patterned magnet layer.

Abstract: Provided herein is an apparatus, including a patterned resist overlying a substrate; a number of features of the patterned resist, wherein the number of features respectively includes a number of sidewalls; and a sidewall-protecting material disposed about the number of sidewalls, wherein the sidewall-protecting material is characteristic of a conformal, thin-film deposition, and wherein the sidewall-protecting material facilitates a high-fidelity pattern transfer of the patterned resist to the substrate during etching.